𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Five-year lung cancer survival : Which advanced stage nonsmall cell lung cancer patients attain long-term survival?

✍ Scribed by Tina Wang; Rebecca A. Nelson; Alicia Bogardus; Frederic W. Grannis Jr


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
133 KB
Volume
116
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Postsurgical chemotherapy in stage IB no
✍ Mario Roselli; Sabrina Mariotti; Patrizia Ferroni; Anastasia Laudisi; Davide Min πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 French βš– 192 KB πŸ‘ 1 views

## Abstract Although surgical resection is considered the adequate treatment in early stages of nonsmall cell lung cancer, long‐term survival is not satisfactory and recurrence rate is high. We previously showed that postoperative chemotherapy at stage IB reduces recurrences and prolongs overall su

Survival improvements for advanced stage
✍ Jason A. Zell; S.-H. Ignatius Ou; Argyrios Ziogas; Hoda Anton-Culver πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 145 KB

## Abstract ## BACKGROUND. Survival improvements have been demonstrated for patients with bronchioloalveolar (BAC) nonsmall cell lung cancer (NSCLC) with intrapulmonary satellite T4 nodules compared with other patients with stage IIIB disease, and for ipsilateral intrapulmonary M1 tumors versus co

Prognostic value of symptom burden for o
✍ Xin Shelley Wang; Qiuling Shi; Charles Lu; Ethan M. Basch; Valen E. Johnson; Tit πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 173 KB πŸ‘ 2 views

## Abstract ## BACKGROUND: Patient–reported outcomes have shown independent prognostic value for patients with nonsmall cell lung cancer (NSCLC). However, translating patient‐reported outcomes into useful prognostic information for individual patients has been problematic. ## METHODS: A total of